Neutralizing antibody and protective immunity to SARS coronavirus infection of mice induced by a soluble recombinant polypeptide containing an N-terminal segment of the spike glycoprotein

被引:83
作者
Bisht, H
Roberts, A
Vogel, L
Subbarao, K
Moss, B
机构
[1] NIAID, Viral Dis Lab, NIH, Bethesda, MD 20892 USA
[2] NIAID, Infect Dis Lab, NIH, Bethesda, MD 20892 USA
关键词
polypeptide; glycoprotein; respiratory tract;
D O I
10.1016/j.virol.2005.01.042
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
A secreted, glycosylated polypeptide containing amino acids 14 to 762 of the SARS coronavirus (SARS-CoV) spike protein and a polyhistidine tag was expressed in recombinant baculovirus-infected insect cells. Mice received the affinity-purified protein with either a saponin (QS21) or a Ribi (MPL + TDM) adjuvant subcutaneously and were challenged intranasally with SARS-CoV. Both regimens induced binding and neutralizing antibodies and protection against SARS-CoV intranasal infection. However, the best results were obtained with QS21 and protein, which provided the highest antibody as well as complete protection of the upper and lower respiratory tract. Published by Elsevier Inc.
引用
收藏
页码:160 / 165
页数:6
相关论文
共 24 条
  • [11] Immunological characterization of the spike protein of the severe acute respiratory syndrome coronavirus
    Lu, LQ
    Manopo, I
    Leung, BP
    Chng, HH
    Ling, AE
    Chee, LL
    Ooi, EE
    Chan, SW
    Kwang, J
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (04) : 1570 - 1576
  • [12] The genome sequence of the SARS-associated coronavirus
    Marra, MA
    Jones, SJM
    Astell, CR
    Holt, RA
    Brooks-Wilson, A
    Butterfield, YSN
    Khattra, J
    Asano, JK
    Barber, SA
    Chan, SY
    Cloutier, A
    Coughlin, SM
    Freeman, D
    Girn, N
    Griffith, OL
    Leach, SR
    Mayo, M
    McDonald, H
    Montgomery, SB
    Pandoh, PK
    Petrescu, AS
    Robertson, AG
    Schein, JE
    Siddiqui, A
    Smailus, DE
    Stott, JE
    Yang, GS
    Plummer, F
    Andonov, A
    Artsob, H
    Bastien, N
    Bernard, K
    Booth, TF
    Bowness, D
    Czub, M
    Drebot, M
    Fernando, L
    Flick, R
    Garbutt, M
    Gray, M
    Grolla, A
    Jones, S
    Feldmann, H
    Meyers, A
    Kabani, A
    Li, Y
    Normand, S
    Stroher, U
    Tipples, GA
    Tyler, S
    [J]. SCIENCE, 2003, 300 (5624) : 1399 - 1404
  • [13] SARS virus infection of cats and ferrets
    Martina, BEE
    Haagmans, BL
    Kuiken, T
    Fouchier, RAM
    Rimmelzwaan, GF
    van Amerongen, G
    Peiris, JSM
    Lim, W
    Osterhaus, ADME
    [J]. NATURE, 2003, 425 (6961) : 915 - 915
  • [14] Replication of SARS coronavirus administered into the respiratory tract of African Green, rhesus and cynomolgus monkeys
    McAuliffe, J
    Vogel, L
    Roberts, A
    Fahle, G
    Fischer, S
    Shieh, WJ
    Butler, E
    Zaki, S
    Claire, MS
    Murphy, B
    Subbarao, K
    [J]. VIROLOGY, 2004, 330 (01) : 8 - 15
  • [15] Characterization of a novel coronavirus associated with severe acute respiratory syndrome
    Rota, PA
    Oberste, MS
    Monroe, SS
    Nix, WA
    Campagnoli, R
    Icenogle, JP
    Peñaranda, S
    Bankamp, B
    Maher, K
    Chen, MH
    Tong, SX
    Tamin, A
    Lowe, L
    Frace, M
    DeRisi, JL
    Chen, Q
    Wang, D
    Erdman, DD
    Peret, TCT
    Burns, C
    Ksiazek, TG
    Rollin, PE
    Sanchez, A
    Liffick, S
    Holloway, B
    Limor, J
    McCaustland, K
    Olsen-Rasmussen, M
    Fouchier, R
    Günther, S
    Osterhaus, ADME
    Drosten, C
    Pallansch, MA
    Anderson, LJ
    Bellini, WJ
    [J]. SCIENCE, 2003, 300 (5624) : 1394 - 1399
  • [16] Saponins, IL12 and BCG adjuvant in the FML-vaccine formulation against murine visceral leishmaniasis
    Santos, WR
    de Lima, VMF
    de Souza, EP
    Bernardo, RR
    Palatnik, M
    de Sousa, CBP
    [J]. VACCINE, 2002, 21 (1-2) : 30 - 43
  • [17] Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice
    Subbarao, K
    McAuliffe, J
    Vogel, L
    Fahle, G
    Fischer, S
    Tatti, K
    Packard, M
    Shieh, WJ
    Zaki, S
    Murphy, B
    [J]. JOURNAL OF VIROLOGY, 2004, 78 (07) : 3572 - 3577
  • [18] Sui JH, 2004, P NATL ACAD SCI USA, V101, P2536, DOI 10.1073/pnas.0307140101
  • [19] Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets
    ter Meulen, J
    Bakker, ABH
    van den Brink, EN
    Weverling, GJ
    Martina, BEE
    Haagmans, BL
    Kuiken, T
    de Kruif, J
    Preiser, W
    Spaan, W
    Gelderblom, HR
    Goudsmit, J
    Osterhaus, ADME
    [J]. LANCET, 2004, 363 (9427) : 2139 - 2141
  • [20] Immunization with modified vaccinia virus Ankara-based recombinant vaccine against severe acute respiratory syndrome is associated with enhanced hepatitis in ferrets
    Weingartl, H
    Czub, M
    Czub, S
    Neufeld, J
    Marszal, P
    Gren, J
    Smith, G
    Jones, S
    Proulx, R
    Deschambault, Y
    Grudeski, E
    Andonov, A
    He, RT
    Li, Y
    Copps, J
    Grolla, A
    Dick, D
    Berry, J
    Ganske, S
    Manning, L
    Cao, JX
    [J]. JOURNAL OF VIROLOGY, 2004, 78 (22) : 12672 - 12676